Harbor MedTech

Harbor MedTech, Inc. is a fully integrated, commercial-stage regenerative medicine company focused on advanced orthopedic soft tissue repair solutions using its patented BriDGE® collagen processing technology. The company's BriDGE® technology transforms readily available, intact Type-1 collagen into a bio-friendly, stabilized collagen matrix that activates the patient's own healing cascade. Pre-clinical and clinical experience has demonstrated that BriDGE-processed collagen matrix, when applied to chronic skin wounds or internal soft tissue injuries, accelerates wound healing, activates and supports tissue regeneration, limits scar tissue formation, and limits infectious biofilm formation. Harbor MedTech currently has two FDA-cleared and CE-marked products and a broad pipeline addressing orthobiologic soft tissue (sports medicine) injuries, general surgical repair of hernia and breast reconstruction, and difficult-to-heal chronic skin wounds. The company is headquartered in California and sells its BPMatrix products to surgical and wound-care customers.